N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance

N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance

N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers, and the addition salts thereof, pharmaceutical compositions containing the same, methods of treating pathological insulin resistance, methods of treating pathological insulin resistance and patholog...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: NAGY KAROLY, KUERTHY MARIA, TOEROEK MAGDOLNA, NAGY MELINDA, NAGY ZOLTAN, UEROEGDI LASZLO, KOMAROMI ANDRAS, CSAKAI ZITA, MARVANYOS EDE, BARABAS MIHALY, MOGYOROSI TAMAS, KARDOS MIHALYNE, KORANYI LASZLO, SZILBEREKY JENOE, BIRO KATALIN
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator NAGY KAROLY
KUERTHY MARIA
TOEROEK MAGDOLNA
NAGY MELINDA
NAGY ZOLTAN
UEROEGDI LASZLO
KOMAROMI ANDRAS
CSAKAI ZITA
MARVANYOS EDE
BARABAS MIHALY
MOGYOROSI TAMAS
KARDOS MIHALYNE
KORANYI LASZLO
SZILBEREKY JENOE
BIRO KATALIN
description N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers, and the addition salts thereof, pharmaceutical compositions containing the same, methods of treating pathological insulin resistance, methods of treating pathological insulin resistance and pathological conditions associated therewith, and methods of treating pathological insulin resistance by simultaneously treating diabetes-induced chronic complications, especially retinopathy, neuropathy and nephropathy, and/or by simultaneously increasing pathologically decreased peripheral neuroregeneration caused by diabetes.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US6649628B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US6649628B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US6649628B13</originalsourceid><addsrcrecordid>eNqNirEKwjAURbs4iPoPb9ThDa1SdFUUJxd1EikxeaUP0iQkKTSrX24QP8DpXs450-J9wUeFXVLejgnXuCzRsSPPik3SK-ety-Lp0pcQlmhHVpRLKfwr_56VTRpkp21OCIRRwDHAEAjYQOwIoicRezIRbJtZGHQWngKHKIykeTFphQ60-O2sgNPxdjgjOdtQcEKSodjcr3W92dXVdl-u_0g-xvRJUw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance</title><source>esp@cenet</source><creator>NAGY KAROLY ; KUERTHY MARIA ; TOEROEK MAGDOLNA ; NAGY MELINDA ; NAGY ZOLTAN ; UEROEGDI LASZLO ; KOMAROMI ANDRAS ; CSAKAI ZITA ; MARVANYOS EDE ; BARABAS MIHALY ; MOGYOROSI TAMAS ; KARDOS MIHALYNE ; KORANYI LASZLO ; SZILBEREKY JENOE ; BIRO KATALIN</creator><creatorcontrib>NAGY KAROLY ; KUERTHY MARIA ; TOEROEK MAGDOLNA ; NAGY MELINDA ; NAGY ZOLTAN ; UEROEGDI LASZLO ; KOMAROMI ANDRAS ; CSAKAI ZITA ; MARVANYOS EDE ; BARABAS MIHALY ; MOGYOROSI TAMAS ; KARDOS MIHALYNE ; KORANYI LASZLO ; SZILBEREKY JENOE ; BIRO KATALIN</creatorcontrib><description>N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers, and the addition salts thereof, pharmaceutical compositions containing the same, methods of treating pathological insulin resistance, methods of treating pathological insulin resistance and pathological conditions associated therewith, and methods of treating pathological insulin resistance by simultaneously treating diabetes-induced chronic complications, especially retinopathy, neuropathy and nephropathy, and/or by simultaneously increasing pathologically decreased peripheral neuroregeneration caused by diabetes.</description><edition>7</edition><language>eng</language><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20031118&amp;DB=EPODOC&amp;CC=US&amp;NR=6649628B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20031118&amp;DB=EPODOC&amp;CC=US&amp;NR=6649628B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NAGY KAROLY</creatorcontrib><creatorcontrib>KUERTHY MARIA</creatorcontrib><creatorcontrib>TOEROEK MAGDOLNA</creatorcontrib><creatorcontrib>NAGY MELINDA</creatorcontrib><creatorcontrib>NAGY ZOLTAN</creatorcontrib><creatorcontrib>UEROEGDI LASZLO</creatorcontrib><creatorcontrib>KOMAROMI ANDRAS</creatorcontrib><creatorcontrib>CSAKAI ZITA</creatorcontrib><creatorcontrib>MARVANYOS EDE</creatorcontrib><creatorcontrib>BARABAS MIHALY</creatorcontrib><creatorcontrib>MOGYOROSI TAMAS</creatorcontrib><creatorcontrib>KARDOS MIHALYNE</creatorcontrib><creatorcontrib>KORANYI LASZLO</creatorcontrib><creatorcontrib>SZILBEREKY JENOE</creatorcontrib><creatorcontrib>BIRO KATALIN</creatorcontrib><title>N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance</title><description>N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers, and the addition salts thereof, pharmaceutical compositions containing the same, methods of treating pathological insulin resistance, methods of treating pathological insulin resistance and pathological conditions associated therewith, and methods of treating pathological insulin resistance by simultaneously treating diabetes-induced chronic complications, especially retinopathy, neuropathy and nephropathy, and/or by simultaneously increasing pathologically decreased peripheral neuroregeneration caused by diabetes.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNirEKwjAURbs4iPoPb9ThDa1SdFUUJxd1EikxeaUP0iQkKTSrX24QP8DpXs450-J9wUeFXVLejgnXuCzRsSPPik3SK-ety-Lp0pcQlmhHVpRLKfwr_56VTRpkp21OCIRRwDHAEAjYQOwIoicRezIRbJtZGHQWngKHKIykeTFphQ60-O2sgNPxdjgjOdtQcEKSodjcr3W92dXVdl-u_0g-xvRJUw</recordid><startdate>20031118</startdate><enddate>20031118</enddate><creator>NAGY KAROLY</creator><creator>KUERTHY MARIA</creator><creator>TOEROEK MAGDOLNA</creator><creator>NAGY MELINDA</creator><creator>NAGY ZOLTAN</creator><creator>UEROEGDI LASZLO</creator><creator>KOMAROMI ANDRAS</creator><creator>CSAKAI ZITA</creator><creator>MARVANYOS EDE</creator><creator>BARABAS MIHALY</creator><creator>MOGYOROSI TAMAS</creator><creator>KARDOS MIHALYNE</creator><creator>KORANYI LASZLO</creator><creator>SZILBEREKY JENOE</creator><creator>BIRO KATALIN</creator><scope>EVB</scope></search><sort><creationdate>20031118</creationdate><title>N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance</title><author>NAGY KAROLY ; KUERTHY MARIA ; TOEROEK MAGDOLNA ; NAGY MELINDA ; NAGY ZOLTAN ; UEROEGDI LASZLO ; KOMAROMI ANDRAS ; CSAKAI ZITA ; MARVANYOS EDE ; BARABAS MIHALY ; MOGYOROSI TAMAS ; KARDOS MIHALYNE ; KORANYI LASZLO ; SZILBEREKY JENOE ; BIRO KATALIN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US6649628B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2003</creationdate><toplevel>online_resources</toplevel><creatorcontrib>NAGY KAROLY</creatorcontrib><creatorcontrib>KUERTHY MARIA</creatorcontrib><creatorcontrib>TOEROEK MAGDOLNA</creatorcontrib><creatorcontrib>NAGY MELINDA</creatorcontrib><creatorcontrib>NAGY ZOLTAN</creatorcontrib><creatorcontrib>UEROEGDI LASZLO</creatorcontrib><creatorcontrib>KOMAROMI ANDRAS</creatorcontrib><creatorcontrib>CSAKAI ZITA</creatorcontrib><creatorcontrib>MARVANYOS EDE</creatorcontrib><creatorcontrib>BARABAS MIHALY</creatorcontrib><creatorcontrib>MOGYOROSI TAMAS</creatorcontrib><creatorcontrib>KARDOS MIHALYNE</creatorcontrib><creatorcontrib>KORANYI LASZLO</creatorcontrib><creatorcontrib>SZILBEREKY JENOE</creatorcontrib><creatorcontrib>BIRO KATALIN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NAGY KAROLY</au><au>KUERTHY MARIA</au><au>TOEROEK MAGDOLNA</au><au>NAGY MELINDA</au><au>NAGY ZOLTAN</au><au>UEROEGDI LASZLO</au><au>KOMAROMI ANDRAS</au><au>CSAKAI ZITA</au><au>MARVANYOS EDE</au><au>BARABAS MIHALY</au><au>MOGYOROSI TAMAS</au><au>KARDOS MIHALYNE</au><au>KORANYI LASZLO</au><au>SZILBEREKY JENOE</au><au>BIRO KATALIN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance</title><date>2003-11-18</date><risdate>2003</risdate><abstract>N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers, and the addition salts thereof, pharmaceutical compositions containing the same, methods of treating pathological insulin resistance, methods of treating pathological insulin resistance and pathological conditions associated therewith, and methods of treating pathological insulin resistance by simultaneously treating diabetes-induced chronic complications, especially retinopathy, neuropathy and nephropathy, and/or by simultaneously increasing pathologically decreased peripheral neuroregeneration caused by diabetes.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US6649628B1
source esp@cenet
title N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T01%3A37%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NAGY%20KAROLY&rft.date=2003-11-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS6649628B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true